United Kingdom (UK) – Healthcare, Regulatory and Reimbursement Landscape
GlobalData, the industry analysis specialist, has released its latest report, "United Kingdom (UK) – Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the UK. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The UK healthcare market is one of the most promising market globally, with universal health coverage and a strong focus on R&D in the field of genomics, artificial intelligence (AI), early-stage diagnostics, and big data. The UK pharmaceutical market increased from £13.77B in 2012 to £21.84B in 2019 at a Compound Annual Growth Rate (CAGR) of 6.8%. In terms of US Dollars, the market increased from $21.76B in 2012 to $29.42B in 2019 at a CAGR of 3.8%. It is forecast to reach about $35.52B in 2025. The key drivers contributing to the growth of the UK pharmaceutical market are universal healthcare coverage, the growing elderly population, increased access to healthcare services, high disease burden, and innovation in personalized medicines. However, the increased focus on generic drugs will be a barrier to the pharmaceutical market.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the UK, and includes:
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, GSK, AstraZeneca, and Merck
Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Roche Diagnostics, Siemens Healthineers, and Smith & Nephew
An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
An overview of the opportunities for and challenges to growth in the UK healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
Develop business strategies by understanding the trends shaping and driving the UK’s healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the UK’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
List of Tables
List of Figures
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Still undecided about purchasing this report?
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Related reports
View more Pharmaceuticals reports